Former President of Eli Lilly Research Labs and Head of R&D Dr. Jan Lundberg invests in Sigrid Therapeutics and joins the Company’s Scientific Advisory Board
Stockholm, Sweden June 1[st] , 2020. Sigrid Therapeutics, a Swedish clinical stage technology company specializing in prevention of type-2 diabetes and treatment of obesity, today announced that internationally renowned pharmaceutical R&D leader, Dr. Jan Lundberg has joined the Company as an investor and member of the Scientific Advisory Board. The appointment follows shortly after the publication of additional proof of concept for Sigrid’s medical device SiPore15[TM] for preventing diabetes and obesity.Dr. Jan Lundberg has more than 20 years of leadership experience from executive